Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
PROCEPT BioRobotics Corporation - Common Stock
(NQ:
PRCT
)
56.03
-1.56 (-2.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PROCEPT BioRobotics Corporation - Common Stock
< Previous
1
2
3
4
5
Next >
Procept BioRobotics Shares Are Higher Today, CEO Touts 'Strong Surgeon Interest'
January 09, 2024
Procept BioRobotics Corp (NASDAQ: PRCT) shares are trading higher after the company announced fourth-quarter (Q4) FY23
Via
Benzinga
Demystifying PROCEPT BioRobotics: Insights From 4 Analyst Reviews
January 09, 2024
Via
Benzinga
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
January 08, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Stock Scores Rising Relative Strength
December 05, 2023
The Relative Strength (RS) Rating for PROCEPT BioRobotics stock headed into a new percentile Tuesday, as it got a lift from 70 to 77.
Via
Investor's Business Daily
PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
November 13, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
November 01, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
The 7 Best Tech Stocks To Buy Now: October 2023
October 22, 2023
Although the innovation sector got overheated, certain underappreciated ideas make up the best tech stocks to buy now.
Via
InvestorPlace
PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
October 16, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation
October 12, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
September 20, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
September 12, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
August 22, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
August 17, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
NorthShore University HealthSystem offers expanded access to treat most common prostate ailment
August 16, 2023
Highland Park Hospital adds second AquaBeam system, Swedish Hospital installs first
From
PROCEPT BioRobotics; NorthShore University HealthSystem
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
August 11, 2023
Via
Benzinga
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock
August 01, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
August 01, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
July 27, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023
July 11, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
May 31, 2023
Via
Benzinga
7 Growth Stocks That Could Double Your Money in 2023
May 14, 2023
For investors that really want to roll the dice, these are the enticing growth stocks that could double your money.
Via
InvestorPlace
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm
April 28, 2023
From
The Schall Law Firm
Via
Business Wire
Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday
April 28, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates
April 28, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm
April 27, 2023
From
The Schall Law Firm
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
April 27, 2023
Via
Benzinga
Why Shares of Procept Biorobotics Were Slumping Thursday
April 27, 2023
The company released first-quarter earnings on Thursday morning.
Via
The Motley Fool
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
April 27, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 27, 2023
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its...
Via
Benzinga
Earnings Scheduled For April 27, 2023
April 27, 2023
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.